Flunisolide (inhalation)

Revision as of 18:40, 27 September 2011 by WikiBot (talk | contribs) (Protected "Flunisolide": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Flunisolide (inhalation)
Clinical data
Routes of
administration
Inhaled
ATC code
Pharmacokinetic data
Protein binding40% after oral inhalation
Elimination half-life1.8 hours
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC24H31FO6
Molar mass434.498 g/mol

Flunisolide (marketed as AeroBid, Nasalide, Nasarel) is a corticosteroid often prescribed as treatment for allergic rhinitis.

The principal mechanism of action of flunisolide is to activate glucocorticoid receptors. It also has anti-inflammatory action.


Template:Corticosteroids


Template:Pharma-stub Template:WikiDoc Sources